Sex Differences in Symptom Complexity and Door-to-Balloon Time in Patients With ST-Elevation Myocardial Infarction

John E Brush1, Sarwat I Chaudhry2, Rachel P Dreyer3

  • 1Sentara Healthcare and Eastern Virginia Medical School, Norfolk, Virginia.

Insights

Young women with ST-elevation myocardial infarction (STEMI) present with more complex symptoms, potentially delaying critical door-to-balloon times. This complexity, particularly non-chest pain symptoms, is linked to longer treatment delays or no percutaneous coronary intervention.

Area of Science:

  • Cardiology
  • Medical Research

Background:

  • Greater symptom complexity in women compared to men may impede timely recognition of acute ST-elevation myocardial infarction (STEMI).
  • This can lead to delays in crucial door-to-balloon (D2B) times, impacting patient outcomes.

Purpose of the Study:

  • To investigate sex differences in symptom complexity among STEMI patients.
  • To determine the relationship between symptom complexity and D2B times in young and older STEMI patients.

Main Methods:

  • Analysis of data from 1,677 STEMI patients from the VIRGO and SILVER-AMI studies.
  • Symptom complexity defined by number of phenotypes and average symptoms; comparisons using Monte Carlo permutation testing, generalized linear, and logistic regression.

Main Results:

  • Young women exhibited significantly more symptom phenotypes and a higher average number of symptoms than young men.
  • Young women also experienced longer mean D2B times compared to young men.
  • No significant differences in symptom complexity or D2B times were observed between older women and older men.
  • While overall symptom complexity wasn't linked to D2B time, young women reporting more symptom phenotypes had longer D2B times or did not receive percutaneous coronary intervention (PCI).
  • Young women were more likely to report non-chest pain symptoms, which may slow STEMI recognition.

Conclusions:

  • Symptom complexity markers were not universally associated with D2B time in STEMI patients.
  • Increased symptom phenotypes in young women were associated with prolonged D2B time or lack of PCI.
  • The higher prevalence of non-chest pain symptoms in young women may contribute to delayed STEMI recognition and treatment.
  • Further research into symptom clusters is needed to enhance STEMI recognition and improve D2B times in young women.

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
15
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
38
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
29
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
17
Angina III: Clinical Manifestations and Assessment01:29

Angina III: Clinical Manifestations and Assessment

Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
16
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
27